Valuation: 4DMedical Limited

Market Cap 2.34B 1.64B 1.43B 1.32B 1.22B 2.3B 157B 15.78B 6.19B 77.06B 6.15B 6.02B 265B P/E 2026 *
-12.3x
P/E 2027 * -62.3x
Enterprise Value 2.08B 1.45B 1.27B 1.17B 1.08B 2.04B 140B 14B 5.49B 68.37B 5.46B 5.34B 235B EV / Sales 2026 *
249x
EV / Sales 2027 * 95.1x
Free-Float
93.2%
Yield 2026 *
-
Yield 2027 * -
1 day+0.38%
1 week-4.27%
Current month-13.36%
1 month+4.39%
3 months-37.99%
6 months-13.36%
Current year-0.13%
1 week 3.72
Extreme 3.72
4.21
1 month 3.57
Extreme 3.57
5.08
Current year 2.95
Extreme 2.95
7.55
1 year 0.23
Extreme 0.23
7.55
3 years 0.22
Extreme 0.225
7.55
5 years 0.22
Extreme 0.225
7.55
10 years 0.22
Extreme 0.225
7.55
Manager TitleAgeSince
Chief Executive Officer - 01/12/2012
Director of Finance/CFO - 02/01/2026
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Director/Board Member - 01/12/2012
Chairman - 02/11/2023
Director/Board Member - 01/10/2017
Date Insider Type Main position Quantity % Market Cap.
06-19Buy

Chief Financial Officer

11,363 0.0019%
06-19Fiscal year

Chairman

-308,394 0.0518%
06-19Fiscal year

Chairman

308,394 0.0518%
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%-4.27%+1,470.00%+477.21% 1.64B
+1.05%+3.38%+25.56%+0.89% 198B
-6.78%-11.19%-26.52%+7.20% 134B
-0.55%+2.50%+0.66%-17.25% 141B
-4.52%-5.89%-59.14%-19.61% 63.36B
-1.85%-4.99%+15.09%-3.52% 51.87B
-3.57%-2.72%-25.44%-33.65% 43.77B
+0.87%+3.10%+12.59%+12.90% 38.18B
+0.85%+0.39%+23.74%+39.01% 36.96B
-5.59%-4.98%-17.18%-24.64% 28.05B
Average -1.42%-2.72%+141.94%+43.85% 73.76B
Weighted average by Cap. -1.44%-1.18%+1.10%-2.93%

Financials

2026 *2027 *
Net sales 8.34M 5.83M 5.09M 4.71M 4.35M 8.19M 560M 56.15M 22.03M 274M 21.89M 21.41M 944M 22.25M 15.55M 13.59M 12.56M 11.61M 21.86M 1.49B 150M 58.78M 731M 58.41M 57.12M 2.52B
Net income -177M -124M -108M -99.95M -92.34M -174M -11.88B -1.19B -468M -5.82B -465M -454M -20.04B -37.1M -25.92M -22.65M -20.94M -19.35M -36.44M -2.49B -250M -97.99M -1.22B -97.37M -95.22M -4.2B
Net Debt -264M -185M -162M -149M -138M -260M -17.75B -1.78B -699M -8.69B -694M -679M -29.93B -228M -160M -139M -129M -119M -224M -15.33B -1.54B -603M -7.51B -599M -586M -25.84B
Logo 4DMedical Limited
4DMedical Limited is a medical technology company that creates and deploys software-based cardiothoracic imaging technology integrating both algorithms and artificial intelligence. The Company's software platform delivers quantitative insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease. It provides thoracic imaging that enhances physician diagnoses and management of respiratory conditions. Its products include CT:VQ-Non-Contrast Ventilation-Perfusion, CAC-Coronary Artery Calcification, CT LVAS-Lung Ventilation Analysis, IQ-UIP-Early IPF Detection, LDAf-Functional Lung Density Analysis, LDAi-Lung Density Analysis – Inspiration, LTA-Lung Texture Analysis, PHA-Pulmonary Hypertension Assessment, XV LVAS-Lung Ventilation Analysis, and Companion Imaging. The CT:VQ is a non-contrast post-processing technology that transforms routine, chest computed tomographies (CTs) into quantitative, lobar ventilation (V) and perfusion (Q) maps.
Employees
124
Date Price Change Volume
15/07/26 A$3.930 +0.51% 2,064,458
14/07/26 A$3.910 -1.51% 6,728,083
13/07/26 A$3.970 +0.25% 6,171,692
10/07/26 A$3.960 -2.46% 6,874,373
09/07/26 A$4.060 -0.98% 4,362,023
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3.910AUD
Average target price
4.967AUD
Spread / Average Target
+27.02%

Quarterly revenue - Rate of surprise